Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse

Yan Teng1, An-Na Sun, Xiao-Chen Pan

  • 1Genetic Laboratory of Development and Diseases, Institute of Biotechnology and National Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P.R. China.

Cancer Research
|July 20, 2006
PubMed

Insights

Coordinated deletion of Smad4 and PTEN genes accelerates forestomach cancer in mice. This highlights the synergistic role of these genes in suppressing esophageal squamous cell carcinoma (SCC) development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Esophageal tumorigenesis genetic basis is poorly understood.
  • Coordinated deletion of Smad4 and PTEN genes in mice leads to skin tumors.
  • Smad4 and PTEN are critical tumor suppressors.

Purpose of the Study:

  • To investigate the role of Smad4 and PTEN in forestomach carcinogenesis.
  • To understand the genetic mechanisms underlying esophageal squamous cell carcinoma (SCC).

Main Methods:

  • Generation of Smad4 and PTEN double knockout mice.
  • Histopathological analysis of forestomach tumors.
  • Assessment of cell proliferation markers and cell cycle regulators.

Main Results:

  • Concomitant inactivation of Smad4 and PTEN accelerates forestomach SCC formation with complete penetrance.
  • Tumors recapitulated human esophageal SCC features, with some exhibiting adenocarcinomas.
  • Increased epithelial proliferation and altered expression of cell cycle inhibitors (p27, p21, p16, cyclin D1) were observed.

Conclusions:

  • Synergy between Smad4 and PTEN is crucial for suppressing forestomach tumorigenesis.
  • These genes cooperate to induce cell cycle inhibitors, preventing SCC development.
  • Understanding this pathway offers insights into esophageal cancer prevention and treatment.